Delivery Order SPE2DB20D2014-SPE2DB25FB47G

Award Date 3/27/25
Potential Completion Date 3/28/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,085.64, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is January 6, 2025. The contract is for the pharmaceutical product HUMIRA(CF) PEN 40 MG/0.4 MLS. This contract award is not associated with a set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
This federal contract award, valued at $3,476.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product. The contract is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award, valued at $5,287.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of HUMIRA PEN 40 MG/0.8 MLS. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 16, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation for this award. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award, with ID SPE2DB22D3501|SPE2DB25FTP26, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,911.04 delivery order contract is for the supply of HUMIRA PEN 40 MG/0.8 MLS pharmaceutical products. The contract has a firm fixed price and an ultimate completion date of November 22, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $6,536.42 firm fixed price delivery order is for the supply of HUMIRA PEN 40 MG/0.8 MLS, a pharmaceutical product, to support military treatment programs and facilities. This award is part of a larger indefinite delivery contract (IDC) valued at up to...
This federal contract award, valued at $14,191.98, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, with a completion date of March 24, 2025. This appears to be a Firm Fixed Price Delivery Order contract, without any set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $2,265.90, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of HUMIRA PEN 40 MG/0.8 MLS, a medical product. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as...
This federal contract award, with ID SPE2DB22D3301|SPE2DB24FX8EF, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $45,082.30, is a Firm Fixed Price Delivery Order for the supply of HUMIRA PEN 40 MG/0.8 MLS, a pharmaceutical product. The contract has an ultimate completion date of January 8, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that supplies medical...
This federal contract award, valued at $16,457.13, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS medication, which is a critical care pharmaceutical product. The contract is a fixed-price delivery order with a completion date of September 12, 2024. This award is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, issued by the Defense Logistics Agency (DLA), was made to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $1,931.01 firm fixed price delivery order is for the supply of HUMIRA PEN 40 MG/0.8 MLS to support military treatment programs and facilities. This award is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which enables...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FB47G
    Delivery Order

This federal contract award, valued at $1,132.95, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of March 28, 2025. The contract covers the procurement of HUMIRA PEN 40 MG/0.8 MLS, a pharmaceutical product. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that provides a comprehensive range of medical products, prescription drugs, and healthcare solutions to federal government agencies, including the military and veterans' healthcare programs. The company holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for supplying pharmaceutical and medical supplies to support military healthcare globally. This specific award is likely part of the broader DLA IDC contract.

Generated 6/26/25, 9:52 AM